FDA Proposes Expedited Investigational New Drug Pilot Program to Drive Early Phase Clinical Research in the United States
On June 22, 2026, the U.S. Department of Health and Human Services (HHS) unveiled Operation TrialBlazer, a department-wide effort to accelerate clinical research and development centered in the…
Read the full articleYou might also wanna read
HHS Launches Department-Wide Initiative to Revitalize US Leadership in Clinical Trials
HHS announced a coordinated department-wide effort to strengthen America’s leadership in clinical research.
hhs.gov·17d ago
HHS and FDA announce reforms to accelerate clinical trials and restore US research leadership
A welcome move from the FDA and HHS
writingruxandrabio.com·18d ago
FDA to launch pilot program to speed up early-stage clinical trials
Federal health officials aim to speed up drug development and better compete with China.
statnews.com·18d agoThe State of the U.S. Biomedical and Health Research Enterprise Strategies for Achieving a Healthier America
Final Book Now Available The U.S. biomedical research enterprise has played a vital role in advancing science, human health, and the economy
FDA Leverages Real-World Data and Partnerships to Accelerate COVID-19 Response
Learn about FDA’s innovative approaches to respond to COVID-19 as quickly and safely as possible.
fda.gov·4d ago
NHS Fast-tracks Life-changing Medicines in Landmark UK-US Access Overhaul
A new series of NHS pilot schemes could give patients access to innovative medicines months earlier while supporting investment in the UK's
Comments
Sign in to join the conversation.
No comments yet. Be the first.